| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | David E Williams | |
| Sharon K Krueger | |||
| P2860 | cites work | The flavin-containing monooxygenase 2 gene (FMO2) of humans, but not of other primates, encodes a truncated, nonfunctional protein | Q22004271 |
| In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily | Q23916231 | ||
| Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein | Q24292035 | ||
| Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione | Q24293146 | ||
| Oxidation of caffeine to theobromine and theophylline is catalyzed primarily by flavin-containing monooxygenase in liver microsomes | Q24314549 | ||
| Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics | Q24539077 | ||
| Crystal structure of a Baeyer-Villiger monooxygenase | Q24561935 | ||
| Yeast flavin-containing monooxygenase generates oxidizing equivalents that control protein folding in the endoplasmic reticulum | Q24673769 | ||
| N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication | Q28137664 | ||
| Immunoquantitation of FMO1 in human liver, kidney, and intestine | Q28144175 | ||
| Mild trimethylaminuria caused by common variants in FMO3 gene | Q28144334 | ||
| Two novel mutations of the FMO3 gene in a proband with trimethylaminuria | Q28144483 | ||
| Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6) | Q28182512 | ||
| Cytochrome P450 2C8 and flavin-containing monooxygenases are involved in the metabolism of tazarotenic acid in humans | Q28184203 | ||
| New metabolic pathways of alpha-lipoic acid | Q28189129 | ||
| Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans | Q28203039 | ||
| 6-methylhydroxylation of the anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by flavin-containing monooxygenase 3 | Q28205470 | ||
| Identification of human drug-metabolizing enzymes involved in the metabolism of SNI-2011 | Q28207926 | ||
| Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression | Q28216584 | ||
| The antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase | Q28217168 | ||
| Chemical and biological evolution of nucleotide-binding protein | Q28240624 | ||
| Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine | Q28249334 | ||
| Stereoselective metabolism of (S)-(-)-nicotine in humans: formation of trans-(S)-(-)-nicotine N-1'-oxide | Q28250108 | ||
| The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression | Q28250605 | ||
| Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome | Q28256555 | ||
| A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities | Q28259625 | ||
| Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication | Q28267159 | ||
| Three-dimensional structure of glutathione reductase at 2 Å resolution | Q28281753 | ||
| Expression and characterization of a modified flavin-containing monooxygenase 4 from humans | Q28284425 | ||
| The molecular biology of the flavin-containing monooxygenases of man | Q28300051 | ||
| Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans | Q28300061 | ||
| Flavin-containing monooxygenase mediated metabolism of psychoactive drugs by human brain microsomes | Q28301383 | ||
| Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system | Q28330781 | ||
| New sequence motifs in flavoproteins: evidence for common ancestry and tools to predict structure | Q28369348 | ||
| Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FM03 gene mutations in a Korean population | Q28374623 | ||
| Sequencing, expression, and characterization of cDNA expressed flavin-containing monooxygenase 2 from mouse | Q28507596 | ||
| Rat liver flavin-containing monooxygenase (FMO): cDNA cloning and expression in yeast | Q28577889 | ||
| Cloning, sequencing and tissue distribution of rat flavin-containing monooxygenase 4: two different forms are produced by tissue-specific alternative splicing | Q28579447 | ||
| Multisubstrate flavin-containing monooxygenases: applications of mechanism to specificity | Q28679232 | ||
| Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms. | Q30766881 | ||
| Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenases. | Q53968891 | ||
| NADPH-dependent oxidation of reduced ebselen, 2-selenylbenzanilide, and of 2-(methylseleno)benzanilide catalyzed by pig liver flavin-containing monooxygenase | Q54066252 | ||
| Effects of genetic or chemically induced diabetes on imipramine metabolism. Respective involvement of flavin monooxygenase and cytochrome P-450-dependent monooxygenases. | Q54404822 | ||
| Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria. | Q54561055 | ||
| Characterization of two human flavin-containing monooxygenase (form 3) enzymes expressed in Escherichia coli as maltose binding protein fusions. | Q54561103 | ||
| Prochiral sulfides as in vitro probes for multiple forms of the flavin-containing monooxygenase. | Q54613648 | ||
| Prochiral sulfoxidation as a probe for multiple forms of the microsomal flavin-containing monooxygenase: studies with rabbit FMO1, FMO2, FMO3, and FMO5 expressed in Escherichia coli. | Q54632225 | ||
| Functional characterization of flavin-containing monooxygenase 1B1 expressed in Saccharomyces cerevisiae and Escherichia coli and analysis of proposed FAD- and membrane-binding domains. | Q54660502 | ||
| Identification of a Baeyer-Villiger monooxygenase sequence motif | Q56900855 | ||
| A hydrophobic sequence motif common to N-hydroxylating enzymes | Q57978321 | ||
| Studies on the chirality of sulfoxidation catalyzed by bacterial flavoenzyme cyclohexanone monooxygenase and hog liver FAD-containing monooxygenase | Q58483904 | ||
| Two novel single nucleotide polymorphisms (SNPs) of the FMO3 gene in Japanese. | Q64912692 | ||
| Hepatic microsomal mixed-function amine oxidase | Q67358280 | ||
| Covalent binding of 14C- and 35S-labeled thiocarbamides in rat hepatic microsomes | Q67532333 | ||
| Metabolism of benzimidazoline-2-thiones by rat hepatic microsomes and hog liver flavin-containing monooxygenase | Q67589138 | ||
| Neurotoxins: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1,2,3,4-tetrahydroisoquinoline and 1-methyl-6,7-dihydroxy-tetrahydroisoquinoline as substrates for FAD-containing monooxygenase of porcine liver microsomes | Q67591976 | ||
| The effect of Hg2+ on rabbit hepatic and pulmonary solubilized, partially purified N,N-dimethylaniline N-oxidases | Q67693457 | ||
| Microsomal mixed-function oxidase-dependent renaturation of reduced ribonuclease | Q67707927 | ||
| Thiobenzamide-induced hepatotoxicity: effects of substituents and route of administration on the nature and extent of liver injury | Q67768998 | ||
| Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes. Evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage | Q67886851 | ||
| Multiple forms of liver microsomal flavin-containing monooxygenases: complete covalent structure of form 2 | Q67981472 | ||
| Protection of rats against the effects of alpha-naphthylthiourea (ANTU) by elevation of non-protein sulphydryl levels | Q67997594 | ||
| Rat hepatic microsomal metabolism of ethylenethiourea. Contributions of the flavin-containing monooxygenase and cytochrome P-450 isozymes | Q68001782 | ||
| The role of cytochromes P-450 and flavin-containing monooxygenase in the metabolism of (S)-nicotine by rabbit lung | Q68095471 | ||
| Microsomal oxidation of dodecylthioacetic acid (a 3-thia fatty acid) in rat liver | Q68294966 | ||
| Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases | Q68783087 | ||
| Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations | Q68794452 | ||
| The N-oxidation of alkylhydrazines catalyzed by the microsomal mixed-function amine oxidase | Q69569248 | ||
| The relative participation of liver microsomal amine oxidase and cytochrome P-450 in N-demethylation reactions | Q41278083 | ||
| Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. | Q41315418 | ||
| Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases | Q41500976 | ||
| Primary aromatic amines: their N-oxidative bioactivation | Q41590929 | ||
| Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes | Q41610819 | ||
| Flavin-containing monooxygenase-dependent stereoselective S-oxygenation and cytotoxicity of cysteine S-conjugates and mercapturates | Q41636016 | ||
| Population-specific polymorphisms of the human FMO3 gene: significance for detoxication | Q41714991 | ||
| Size limits of thiocarbamides accepted as substrates by human flavin-containing monooxygenase 1. | Q42056202 | ||
| Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions | Q42224865 | ||
| Metabolism of phosphorus-containing compounds by pig liver microsomal FAD-containing monooxygenase | Q42227776 | ||
| Rabbit lung flavin-containing monooxygenase is immunochemically and catalytically distinct from the liver enzyme | Q42249402 | ||
| Studies on N-demethylation of methamphetamine by liver microsomes of guinea-pigs and rats: the role of flavin-containing mono-oxygenase and cytochrome P-450 systems | Q42250916 | ||
| Guanethidine N-oxide formation as a measure of cellular flavin-containing monooxygenase activity | Q42259495 | ||
| Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime | Q42547874 | ||
| Studies on the discontinuous N-oxidation of trimethylamine among Jordanian, Ecuadorian and New Guinean populations | Q42550120 | ||
| Isolation and structure of a third form of liver microsomal flavin monooxygenase | Q42603718 | ||
| Pulmonary toxicity of thioureas in the rat. | Q43227788 | ||
| In vitro evaluation of the disposition of A novel cysteine protease inhibitor. | Q43508454 | ||
| Accumulation of the 1-methyl-4-phenylpyridinium ion in suncus (Suncus murinus) brain: implication for flavin-containing monooxygenase activity in brain microvessels | Q43547769 | ||
| Trimethylaminuria: the fish malodor syndrome | Q43548058 | ||
| A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria | Q43552028 | ||
| Characterization of expressed full-length and truncated FMO2 from rhesus monkey | Q43575408 | ||
| In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene | Q43680703 | ||
| Mechanisms for the cytotoxicity of cysteamine | Q43710220 | ||
| Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities | Q43843786 | ||
| Role of yeast flavin-containing monooxygenase in maintenance of thiol-disulfide redox potential | Q43909856 | ||
| The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans | Q43997512 | ||
| Thiourea toxicity in mouse C3H/10T1/2 cells expressing human flavin-dependent monooxygenase 3. | Q44047239 | ||
| N-oxidation and demethylation of N,N-dimethylaniline by rabbit liver and lung microsomes. Effects of age and metals | Q44062607 | ||
| Sulfoxides as urinary metabolites of S-allyl-L-cysteine in rats: evidence for the involvement of flavin-containing monooxygenases | Q44135081 | ||
| Stereoselective N-oxygenation of zimeldine and homozimeldine by the flavin-containing monooxygenase | Q44178326 | ||
| Effects of olopatadine, a new antiallergic agent, on human liver microsomal cytochrome P450 activities | Q44217913 | ||
| Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression | Q44264790 | ||
| Sulphoxidation of ethyl methyl sulphide, 4-chlorophenyl methyl sulphide and diphenyl sulphide by purified pig liver flavin-containing monooxygenase | Q44273092 | ||
| Expression and characterization of functional dog flavin-containing monooxygenase 1. | Q44278260 | ||
| Deactivation of sulindac-sulphide by human renal microsomes | Q44354370 | ||
| Hepatotoxicity of ketoconazole in Sprague-Dawley rats: glutathione depletion, flavin-containing monooxygenases-mediated bioactivation and hepatic covalent binding | Q44440251 | ||
| Involvement of cytochrome P450 and the flavin-containing monooxygenase(s) in the sulphoxidation of simple sulphides in human liver microsomes | Q44448193 | ||
| Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies | Q44483223 | ||
| In vitro metabolism of clindamycin in human liver and intestinal microsomes | Q44483232 | ||
| Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines. XII. Enantioselectivity and temperature dependence in microsomes and reconstituted cytochrome P-450 systems from rat liver | Q44486694 | ||
| Critical role of histidine residues in cyclohexanone monooxygenase expression, cofactor binding and catalysis | Q44641672 | ||
| Gene expression profiling of oxidative stress on atrial fibrillation in humans | Q44674855 | ||
| S-oxidation of S-methyl-esonarimod by flavin-containing monooxygenases in human liver microsomes | Q44741194 | ||
| Effect of total parenteral nutrition and choline on hepatic flavin-containing and cytochrome P-450 monooxygenase activity in rats | Q44743386 | ||
| Evaluation of xenobiotic N- and S-oxidation by variant flavin-containing monooxygenase 1 (FMO1) enzymes | Q44771795 | ||
| Comparative cytotoxicity of N-substituted N'-(4-imidazole-ethyl)thiourea in precision-cut rat liver slices. | Q44787991 | ||
| Cysteamine alters redox state, HIF-1alpha transcriptional interactions and reduces duodenal mucosal oxygenation: novel insight into the mechanisms of duodenal ulceration | Q44816467 | ||
| Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle | Q44853297 | ||
| The flavin-containing monooxygenase in mouse lung: evidence for expression of multiple forms | Q44856453 | ||
| The effect of detergents on the purified flavin-containing monooxygenase of mouse liver, kidney and lungs | Q44857039 | ||
| The flavin-containing monooxygenase of mouse kidney. A comparison with the liver enzyme | Q44857922 | ||
| Stereospecificity in the oxidation of phorate and phorate sulphoxide by purified FAD-containing mono-oxygenase and cytochrome P-450 isozymes | Q44861567 | ||
| Metabolism of thioridazine by microsomal monooxygenases: relative roles of P450 and flavin-containing monooxygenase. | Q44862826 | ||
| Pulmonary flavin-containing monooxygenase (FMO) in rhesus macaque: expression of FMO2 protein, mRNA and analysis of the cDNA. | Q36849602 | ||
| Yeast flavin-containing monooxygenase is induced by the unfolded protein response | Q37143530 | ||
| Genetic polymorphism of trimethylamine N-oxidation | Q38140229 | ||
| Purification and comparison of liver microsomal flavin-containing monooxygenase from normal and streptozotocin-diabetic rats | Q38346500 | ||
| Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria | Q38351957 | ||
| Studies on the mechanism of toxicity and of development of tolerance to the pulmonary toxin, alpha-naphthylthiourea (ANTU) | Q39107578 | ||
| Microsomal mixed-function amine oxidase. Oxidation products of piperazine-substituted phenothiazine drugs | Q39195831 | ||
| Superoxide radical as an intermediate in the oxidation of hydroxylamines by mixed function amine oxidase | Q39240082 | ||
| The liver microsomal FAD-containing monooxygenase. Spectral characterization and kinetic studies | Q39252752 | ||
| Species, organ and cellular variation in the flavin-containing monooxygenase | Q39584079 | ||
| Flavin-containing monooxygenases: catalytic mechanism and substrate specificities | Q39654203 | ||
| Studies on the Nature and Regulation of the Cellular Thiol:Disulphide Potential | Q39858903 | ||
| The Metabolism of Insecticides: The Role of Monooxygenase Enzymes | Q40179304 | ||
| Toxicology of thiono-sulfur compounds | Q40331713 | ||
| The FSSP database of structurally aligned protein fold families | Q40401060 | ||
| Potential role of the flavin-containing monooxygenases in the metabolism of endogenous compounds | Q40508481 | ||
| Species differential stereoselective oxidation of a methylsulfide metabolite of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor dual agonist | Q40540018 | ||
| The olivacine derivative s 16020 (9-hydroxy-5,6-dimethyl-N-[2-(dimethylamino)ethyl)-6H-pyrido(4,3-B)-carbazole-1-carboxamide) induces CYP1A and its own metabolism in human hepatocytes in primary culture | Q40601665 | ||
| Activation of molecular oxygen by flavins and flavoproteins. | Q40697821 | ||
| Baculovirus-mediated expression and purification of human FMO3: catalytic, immunochemical, and structural characterization | Q40890111 | ||
| Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases | Q40908165 | ||
| The assessment of flavin-containing monooxygenase activity in intact animals | Q41197123 | ||
| Trimethylamine N-oxygenation and N-demethylation in rat liver microsomes | Q72870606 | ||
| Flavin-containing monooxygenase-mediated N-oxidation of the M(1)-muscarinic agonist xanomeline | Q73019162 | ||
| Redox regulation of yeast flavin-containing monooxygenase | Q73079922 | ||
| Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing mono-oxygenases: studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine | Q73128226 | ||
| N-oxygenation of clozapine by flavin-containing monooxygenase | Q73234162 | ||
| Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism | Q73604653 | ||
| Determination of FAD-binding domain in flavin-containing monooxygenase 1 (FMO1) | Q73728044 | ||
| N-oxygenation of phenethylamine to the trans-oxime by adult human liver flavin-containing monooxygenase and retroreduction of phenethylamine hydroxylamine by human liver microsomes | Q73746641 | ||
| Can caffeine metabolism be used as an in-vivo probe for human flavin-containing monooxygenase activity? | Q73769609 | ||
| A novel mutation in the flavin-containing monooxygenase 3 gene, FM03, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy | Q74012004 | ||
| Isoform specificity of N-deacetyl ketoconazole by human and rabbit flavin-containing monooxygenases | Q74197849 | ||
| Expression of two different FMOs in sheep liver | Q74279923 | ||
| Abnormalities of flavin monooxygenase as an etiology for sideroblastic anemia | Q74342704 | ||
| Cytotoxicity of a series of mono- and di-substituted thiourea in freshly isolated rat hepatocytes: a preliminary structure-toxicity relationship study | Q74505817 | ||
| Sequence variations in the flavin-containing mono-oxygenase 3 gene (FMO3) in fish odour syndrome | Q77362948 | ||
| Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3 | Q77425114 | ||
| Activation of microsomal glutathione S-transferase and inhibition of cytochrome P450 1A1 activity as a model system for detecting protein alkylation by thiourea-containing compounds in rat liver microsomes | Q77752834 | ||
| Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population | Q77905237 | ||
| Methionine S-oxidation in human and rabbit liver microsomes: evidence for a high-affinity methionine S-oxidase activity that is distinct from flavin-containing monooxygenase 3 | Q77967658 | ||
| Contribution of flavin-containing monooxygenase and cytochrome P450 to imipramine N-oxidation in rat hepatic microsomes | Q78006903 | ||
| Flavin-containing monooxygenase-mediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes | Q78045180 | ||
| Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort | Q78233196 | ||
| FORMATION OF AN INTERMEDIATE N-OXIDE IN THE OXIDATIVE DEMETHYIATION OF N,N-DIMETHYIANILINE CATALYZED BY LIVER MICROSOMES | Q86282699 | ||
| The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate | Q31440452 | ||
| Metabolism of a disulfiram metabolite, S-methyl N,N-diethyldithiocarbamate, by flavin monooxygenase in human renal microsomes | Q31835723 | ||
| Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates. | Q31915842 | ||
| Molecular cloning, sequence, and expression of mouse flavin-containing monooxygenases 1 and 5 (FMO1 and FMO5). | Q32064467 | ||
| Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. | Q33201366 | ||
| Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes | Q33901684 | ||
| Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. | Q33910078 | ||
| Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms: detection of expressed protein in African-Americans | Q33922383 | ||
| Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients | Q33976915 | ||
| Alternative processing of the human FMO6 gene renders transcripts incapable of encoding a functional flavin-containing monooxygenase | Q34140161 | ||
| PRINTS and its automatic supplement, prePRINTS. | Q34169535 | ||
| Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice | Q34171361 | ||
| Trimethylaminuria and a human FMO3 mutation database | Q34225073 | ||
| Structural and catalytic properties of the mammalian flavin-containing monooxygenase | Q34311922 | ||
| Characterization of flavin-containing monooxygenase 5 (FMO5) cloned from human and guinea pig: evidence that the unique catalytic properties of FMO5 are not confined to the rabbit ortholog | Q34319637 | ||
| Biotransformation of organophosphorus compounds | Q34360437 | ||
| The flavin-containing monooxygenase enzymes expressed in rabbit liver and lung are products of related but distinctly different genes | Q34493449 | ||
| The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes | Q34502898 | ||
| Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. | Q34614591 | ||
| Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism | Q34673357 | ||
| Reactions of the 4a-hydroperoxide of liver microsomal flavin-containing monooxygenase with nucleophilic and electrophilic substrates | Q34694694 | ||
| N-oxygenation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by the rat liver flavin-containing monooxygenase expressed in yeast cells | Q34721316 | ||
| Alpha-lipoic acid in liver metabolism and disease | Q34747466 | ||
| An overview of the mechanism, substrate specificities, and structure of FMOs | Q34818980 | ||
| Genetic polymorphisms of flavin-containing monooxygenase (FMO). | Q34819029 | ||
| Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation | Q34849013 | ||
| Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria. | Q35100379 | ||
| The role of the flavin-containing monooxygenase (EC 1.14.13.8) in the metabolism and mode of action of agricultural chemicals | Q35533274 | ||
| Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress | Q35768380 | ||
| A nonsense mutation in the FMO3 gene underlies fishy off-flavor in cow's milk | Q35806700 | ||
| Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patients | Q35825821 | ||
| In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms | Q36055300 | ||
| Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity | Q36055351 | ||
| Cloning, sequencing, distribution, and expression in Escherichia coli of flavin-containing monooxygenase 1C1. Evidence for a third gene subfamily in rabbits. | Q36782075 | ||
| Xenobiotic biotransforming enzymes in the central nervous system: an isoform of flavin-containing monooxygenase (FMO4) is expressed in rabbit brain | Q44866362 | ||
| Molecular cloning, sequencing, and expression in Escherichia coli of mouse flavin-containing monooxygenase 3 (FMO3): comparison with the human isoform | Q44868855 | ||
| Flavin-containing monooxygenase isoform specificity for the N-oxidation of tamoxifen determined by product measurement and NADPH oxidation | Q44872457 | ||
| Porcine FAD-containing monooxygenase metabolizes lidocaine, bupivacaine and propranolol in vitro | Q44933848 | ||
| Studies on the cytochrome P-450 catalyzed ring alpha-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). | Q44963390 | ||
| S-oxygenation of the thioether organophosphate insecticides phorate and disulfoton by human lung flavin-containing monooxygenase 2. | Q45007440 | ||
| Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients. | Q45009688 | ||
| Differences in FMO2*1 allelic frequency between Hispanics of Puerto Rican and Mexican descent | Q45050361 | ||
| Identification and characterization of the FMO2 gene in Rattus norvegicus: a good model to study metabolic and toxicological consequences of the FMO2 polymorphism. | Q45083439 | ||
| Enantioselective N-oxygenation of verapamil by the hepatic flavin-containing monooxygenase | Q45106363 | ||
| A mutation in the flavin-containing monooxygenase 3 gene and its effects on catalytic activity for N-oxidation of trimethylamine in vitro | Q45201110 | ||
| The effect of methimazole on thioamide bioactivation and toxicity | Q45262503 | ||
| Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide | Q45264840 | ||
| Enantioselective N-oxygenation of chlorpheniramine by the flavin-containing monooxygenase from hog liver | Q45385468 | ||
| Enantioselective S-oxygenation of 2-aryl-1,3-dithiolanes by rabbit lung enzyme preparations. | Q45982401 | ||
| Properties of expressed and native flavin-containing monooxygenases: evidence of multiple forms in rabbit liver and lung | Q46133044 | ||
| S-oxidative cleavage of farnesylcysteine and farnesylcysteine methyl ester by the flavin-containing monooxygenase | Q46136040 | ||
| Use of thiocarbamides as selective substrate probes for isoforms of flavin-containing monooxygenases | Q46209674 | ||
| Formation of glutathionyl-spironolactone disulfide by rat liver cytochromes P450 or hog liver flavin-containing monooxygenases: a functional probe of two-electron oxidations of the thiosteroid? | Q46216706 | ||
| Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans | Q46306966 | ||
| Expression in Escherichia coli of the cloned flavin-containing monooxygenase from pig liver | Q46315184 | ||
| Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes | Q46496103 | ||
| Liver microsome and flavin-containing monooxygenase catalyzed oxidation of organic selenium compounds | Q46716422 | ||
| Estimation of flavin-containing monooxygenase activities in crude tissue preparations by thiourea-dependent oxidation of thiocholine | Q46779434 | ||
| Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase | Q46806772 | ||
| Tertiary amines related to brompheniramine: preferred conformations for N-oxygenation by the hog liver flavin-containing monooxygenase | Q46844193 | ||
| Rabbit lung flavin-containing monooxygenase. Purification, characterization, and induction during pregnancy | Q46899045 | ||
| Substrate specificities of rabbit lung and porcine liver flavin-containing monooxygenases: differences due to substrate size | Q47445222 | ||
| Lung cancer risk and CYP1A1 genotype in African Americans | Q47943724 | ||
| Effect of cysteamine hydrochloride on secretion of growth hormone in male swine | Q48182934 | ||
| The FMO2 gene of laboratory rats, as in most humans, encodes a truncated protein | Q48312846 | ||
| Differences in enzymatic properties of flavin-containing monooxygenase in brain microsomes of rat, mouse, hamster, guinea pig and rabbit. | Q48642976 | ||
| Cerebral metabolism of imipramine and a purified flavin-containing monooxygenase from human brain. | Q48952585 | ||
| Effect of methimazole, an FMO substrate and competitive inhibitor, on the neurotoxicity of 3,3'-iminodipropionitrile in male rats. | Q50509009 | ||
| N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. | Q50530624 | ||
| The flavin-containing monooxygenases in rat liver: evidence for the expression of a second form different from FMO1. | Q50759706 | ||
| Cytochrome P4502D and -2C enzymes catalyze the oxidative N-demethylation of the parkinsonism-inducing substance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rat liver microsomes. | Q50991255 | ||
| Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization. | Q52033109 | ||
| Sulfoxidation of thioether-containing pesticides by the flavin-adenine dinucleotide- dependent monooxygenase of pig liver microsomes. | Q52530696 | ||
| Flavin adenine dinucleotide--dependent monooxygenase: its role in the sulfoxidation of pesticides in mammals. | Q52534815 | ||
| Stereoselective sulfoxidation of the pesticide methiocarb by flavin-containing monooxygenase and cytochrome P450-dependent monooxygenases of rat liver microsomes. Anticholinesterase activity of the two sulfoxide enantiomers. | Q52546979 | ||
| S-oxygenation of thiourea results in the formation of genotoxic products. | Q52564441 | ||
| Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome. | Q52585908 | ||
| S-Oxygenation of N-substituted thioureas catalyzed by the pig liver microsomal FAD-containing monooxygenase | Q52770703 | ||
| In vitro hepatic metabolism of ABT-418 in chimpanzee (Pan troglodytes). A unique pattern of microsomal flavin-containing monooxygenase-dependent stereoselective N'-oxidation. | Q52846035 | ||
| Purification of mixed-function amine oxidase from rat liver microsomes. | Q53561036 | ||
| Effect of inhibitors of the FAD-containing monooxygenase system from rat liver microsomes on monomethylhydrazine metabolism and activation to reactive metabolites | Q69585380 | ||
| Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines | Q69670742 | ||
| Formation of hydrogen peroxide and N-hydroxylated amines catalyzed by pulmonary flavin-containing monooxygenases in the presence of primary alkylamines | Q69712670 | ||
| Studies on substrate specificity of the hog liver flavin-containing monooxygenase. Anionic organic sulfur compounds | Q69714312 | ||
| Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase | Q69858815 | ||
| Identification of distinct hepatic and pulmonary forms of microsomal flavin-containing monooxygenase in the mouse and rabbit | Q69940104 | ||
| Catalytic activity and substrate specificity of the flavin-containing monooxygenase in microsomal systems: characterization of the hepatic, pulmonary and renal enzymes of the mouse, rabbit, and rat | Q69952739 | ||
| Interaction of primary amines with a mixed-function amine oxidase isolated from pig liver microsomes | Q70049974 | ||
| Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA | Q70366802 | ||
| Microsomal oxidase. IV. Properties of a mixed-function amine oxidase isolated from pig liver microsomes | Q70378536 | ||
| Studies of the mechanism of metabolism of thioacetamide s-oxide by rat liver microsomes | Q70438506 | ||
| Increased biliary GSSG efflux from rat livers perfused with thiocarbamide substrates for the flavin-containing monooxygenase | Q70490505 | ||
| Characterization of the purified microsomal FAD-containing monooxygenase from mouse and pig liver | Q70493110 | ||
| Purification of macaque liver flavin-containing monooxygenase: a form of the enzyme related immunochemically to an isozyme expressed selectively in adult human liver | Q70597169 | ||
| Microsomal oxidation of thiobenzamide. A photometric assay for the flavin-containing monooxygenase | Q70719431 | ||
| Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole | Q70727973 | ||
| The oxidation of hydrazine derivatives catalyzed by the purified liver microsomal FAD-containing monooxygenase | Q70730004 | ||
| Further characterization of rat brain flavin-containing monooxygenase. Metabolism of imipramine to its N-oxide | Q71077788 | ||
| Oxidation of aldehydes catalyzed by pig liver flavin-containing monooxygenase | Q71215029 | ||
| Selectivity of flavin-containing monooxygenase 5 for the (S)-sulfoxidation of short-chain aralkyl sulfides | Q71215054 | ||
| S-oxidation of (+)-cis-3,5-dimethyl-2-(3-pyridyl)-thiazolidin-4-one hydrochloride by rat hepatic flavin-containing monooxygenase 1 expressed in yeast | Q71290712 | ||
| Relative hepatotoxicity of substituted thiobenzamides and thiobenzamide-S-oxides in the rat | Q71343506 | ||
| Species differences in pulmonary N-oxidation of chlorpromazine and imipramine | Q71370290 | ||
| Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide | Q71373979 | ||
| Metabolism of alpha-naphthylthiourea by rat liver and rat lung microsomes | Q71506324 | ||
| Characterization of the methionine S-oxidase activity of rat liver and kidney microsomes: immunochemical and kinetic evidence for FMO3 being the major catalyst | Q71530817 | ||
| In vitro microsomal metabolism of hydrazine | Q71546873 | ||
| Discontinuous distribution of N-oxidation of dietary-derived trimethylamine in a British population | Q71728615 | ||
| N-oxygenation of primary amines and hydroxylamines and retroreduction of hydroxylamines by adult human liver microsomes and adult human flavin-containing monooxygenase 3 | Q71746723 | ||
| Trimethylamine N-oxidation in Turkish women with bacterial vaginosis | Q71840310 | ||
| In vitro-in vivo correlations of human (S)-nicotine metabolism | Q71987568 | ||
| Flavin-containing monooxygenase (FMO)-dependent metabolism of methionine and evidence for FMO3 being the major FMO involved in methionine sulfoxidation in rabbit liver and kidney microsomes | Q72037168 | ||
| Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes | Q72208998 | ||
| Role of cytochromes P-450 and flavin-containing monooxygenase in the biotransformation of 4-fluoro-N-methylaniline | Q72217162 | ||
| Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation | Q72232377 | ||
| Metabolism-dependent toxicity of methimazole in the olfactory nasal mucosa | Q72245630 | ||
| A quantitative micro method for the estimation of amine oxides | Q72379928 | ||
| Factors influencing the oxidation of cysteamine and other thiols: implications for hyperthermic sensitization and radiation protection | Q72399316 | ||
| Oxidation of dimethylselenide to dimethylselenoxide by microsomes from rat liver and lung and by flavin-containing monooxygenase from pig liver | Q72411623 | ||
| Stereoselective S-oxidation of flosequinan sulfide by rat hepatic flavin-containing monooxygenase 1A1 expressed in yeast | Q72425583 | ||
| Inhibition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolic activity of porcine FAD-containing monooxygenase by selective monoamine oxidase-B inhibitors | Q72426791 | ||
| Asymmetric metabolic N-oxidation of N-ethyl-N-methylaniline by purified flavin-containing monooxygenase | Q72520295 | ||
| Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit | Q72633049 | ||
| Mechanism of inactivation of thyroid peroxidase by thioureylene drugs | Q72688827 | ||
| Characteristic properties and kinetic analysis with neurotoxins of porcine FAD-containing monooxygenase | Q72773967 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug metabolism | Q1124842 |
| P304 | page(s) | 357-87 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism | |
| P478 | volume | 106 |
| Q43144462 | A common FMO3 polymorphism may amplify the effect of nicotine exposure in sudden infant death syndrome (SIDS). |
| Q99365560 | A flavin-dependent monooxygenase catalyzes the initial step in cyanogenic glycoside synthesis in ferns |
| Q39822252 | A mechanism for bacterial transformation of dimethylsulfide to dimethylsulfoxide: a missing link in the marine organic sulfur cycle |
| Q42722567 | A rapid and sensitive CE method with field-enhanced sample injection and in-capillary derivatization for selenomethionine metabolism catalyzed by flavin-containing monooxygenases |
| Q34697294 | Allelic analyses of the Arabidopsis YUC1 locus reveal residues and domains essential for the functions of YUC family of flavin monooxygenases |
| Q35176411 | Altered radiation responses of breast cancer cells resistant to hormonal therapy |
| Q39253466 | Alternative promoters and repetitive DNA elements define the species-dependent tissue-specific expression of the FMO1 genes of human and mouse |
| Q36941961 | Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected? |
| Q42370667 | An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1. |
| Q37513309 | Analysis of changes in hepatic gene expression in a murine model of tolerance to acetaminophen hepatotoxicity (autoprotection). |
| Q92229907 | Ancestral-sequence reconstruction unveils the structural basis of function in mammalian FMOs |
| Q37214624 | Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver |
| Q41165713 | Association of Flavin Monooxygenase Gene E158K Polymorphism with Chronic Heart Disease Risk. |
| Q34551145 | Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases |
| Q38218540 | Biotransformation and bioactivation reactions of alicyclic amines in drug molecules |
| Q36262624 | Blood Trimethylamine-N-Oxide Originates from Microbiota Mediated Breakdown of Phosphatidylcholine and Absorption from Small Intestine |
| Q36920811 | C. elegans flavin-containing monooxygenase-4 is essential for osmoregulation in hypotonic stress |
| Q39262730 | Cell nonautonomous activation of flavin-containing monooxygenase promotes longevity and health span |
| Q35677610 | Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria |
| Q34359500 | Characterization of human flavin-containing monooxygenase (FMO) 3 and FMO5 expressed as maltose-binding protein fusions |
| Q36540754 | Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms |
| Q37266300 | Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K. |
| Q53063534 | Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. |
| Q47886254 | Chemical Basis for Deuterium Labeling of Fat and NADPH. |
| Q52552920 | Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review. |
| Q54395455 | Cloning, characterization and expression of OsFMO(t) in rice encoding a flavin monooxygenase. |
| Q36182676 | Comparative evaluation of 11 in silico models for the prediction of small molecule mutagenicity: role of steric hindrance and electron-withdrawing groups |
| Q33669522 | Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine |
| Q89720321 | Comparative milk proteome analysis of Kashmiri and Jersey cattle identifies differential expression of key proteins involved in immune system regulation and milk quality |
| Q104471872 | Comparative transcriptomics indicates endogenous differences in detoxification capacity after formic acid treatment between honey bees and varroa mites |
| Q41484322 | Compulsive methamphetamine taking in the presence of punishment is associated with increased oxytocin expression in the nucleus accumbens of rats |
| Q30588556 | Crystallographic evidence of drastic conformational changes in the active site of a flavin-dependent N-hydroxylase |
| Q47785473 | Cytochrome P450 and flavin-containing monooxygenase families: Age-dependent differences in expression and functional activity |
| Q37425658 | Cytochrome P450 metabolism and inhibition: analysis for drug discovery |
| Q37189245 | D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis |
| Q45218281 | Development of a CD-MEKC method for investigating the metabolism of tamoxifen by flavin-containing monooxygenases and the inhibitory effects of methimazole, nicotine and DMXAA. |
| Q46304439 | Development of electrophoretically mediated microanalysis method for the kinetics study of flavin-containing monooxygenase in a partially filled capillary. |
| Q90594112 | Development of potent inhibitors of the human microsomal epoxide hydrolase |
| Q36545025 | Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3. |
| Q27002933 | Developmental pharmacokinetics in pediatric populations |
| Q53001535 | Dietary conjugated linoleic acid affects blood parameters, liver morphology and expression of selected hepatic genes in laying hens. |
| Q50504820 | Dietary dry bean effects on hepatic expression of stress and toxicity-related genes in rats. |
| Q51770720 | Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver. |
| Q36559863 | Different cucumber CsYUC genes regulate response to abiotic stresses and flower development |
| Q35596350 | Differential Fmo3 gene expression in various liver injury models involving hepatic oxidative stress in mice |
| Q37405059 | Differential RNA Expression Profile of Skeletal Muscle Induced by Experimental Autoimmune Myasthenia Gravis in Rats. |
| Q28567676 | Differential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomes |
| Q34338686 | Dimethylsulphidemia: the significance of dimethyl sulphide in extra-oral, blood borne halitosis |
| Q98625321 | Discovery of a histidine-based scaffold as an inhibitor of gut microbial choline trimethylamine-lyase |
| Q50462011 | Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patients. |
| Q38966423 | Drug metabolism by flavin-containing monooxygenases of human and mouse. |
| Q36435702 | Effect of Cytochrome P450 Reductase Deficiency on 2-Amino-9H-pyrido[2,3-b]indole Metabolism and DNA Adduct Formation in Liver and Extrahepatic Tissues of Mice |
| Q38307386 | Effect of dietary α-lipoic acid on the mRNA expression of genes involved in drug metabolism and antioxidation system in rat liver |
| Q41618331 | Effect of human flavin-containing monooxygenase 3 polymorphism on the metabolism of aurora kinase inhibitors |
| Q28570562 | Effect of hyperosmotic conditions on flavin-containing monooxygenase activity, protein and mRNA expression in rat kidney |
| Q85317400 | Effect of two-linked mutations of the FMO3 gene on itopride metabolism in Chinese healthy volunteers |
| Q35686503 | Effects of a Terrified-Sound Stress on Serum Proteomic Profiling in Mice |
| Q37038292 | Effects of ritonavir on adipocyte gene expression: evidence for a stress-related response |
| Q42360866 | Effects of salinity acclimation on the pesticide-metabolizing enzyme flavin-containing monooxygenase (FMO) in rainbow trout (Oncorhynchus mykiss). |
| Q36337990 | Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis |
| Q46089936 | Enantioselective in-line and off-line CE methods for the kinetic study on cimetidine and its chiral metabolites with reference to flavin-containing monooxygenase genetic isoforms |
| Q33609122 | Environmental sensing and response genes in cnidaria: the chemical defensome in the sea anemone Nematostella vectensis. |
| Q40439693 | Escherichia coli Overexpressing a Baeyer-Villiger Monooxygenase from Acinetobacter radioresistens Becomes Resistant to Imipenem. |
| Q30763197 | Eureka-DMA: an easy-to-operate graphical user interface for fast comprehensive investigation and analysis of DNA microarray data |
| Q41830391 | Exploring nicotinamide cofactor promiscuity in NAD(P)H-dependent flavin containing monooxygenases (FMOs) using natural variation within the phosphate binding loop. Structure and activity of FMOs from Cellvibrio sp. BR and Pseudomonas stutzeri NF13. |
| Q45317495 | FMO oxidises nucleophiles |
| Q53033156 | First case of Currarino syndrome and trimethylaminuria: two rare diseases for a complex clinical presentation. |
| Q64084770 | Flavin Conjugated Polydopamine Nanoparticles Displaying Light-Driven Monooxygenase Activity |
| Q95851909 | Flavin Containing Monooxygenases and Metabolism of Xenobiotics |
| Q89452333 | Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk |
| Q33631394 | Flavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated Hepatocytes |
| Q47116870 | Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway. |
| Q37008890 | Flavin-containing monooxygenase 3 and human disease |
| Q48031007 | Flavin-containing monooxygenase 3 gene polymorphisms in Turkish population |
| Q39213310 | Flavin-containing monooxygenase 3 polymorphisms in 13 ethnic populations from Europe, East Asia and sub-Saharan Africa: frequency and linkage analysis |
| Q33946752 | Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones. |
| Q36316996 | Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development. |
| Q34005493 | Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver. |
| Q53204311 | Flavin-containing monooxygenases from Phanerochaete chrysosporium responsible for fungal metabolism of phenolic compounds. |
| Q39313594 | Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes |
| Q92229912 | Flavin-containing monooxygenases: new structures from old proteins |
| Q38648995 | Free radicals and related reactive species as mediators of tissue injury and disease: implications for Health. |
| Q41857015 | Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria |
| Q38619177 | Genetic and Non-genetic Factors Associated with Protein Abundance of Flavin-containing Monooxygenase 3 in Human Liver |
| Q28305656 | Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives |
| Q37187804 | Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects |
| Q36540437 | Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease |
| Q93223495 | Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline |
| Q24539077 | Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics |
| Q34433222 | Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli |
| Q35727337 | Human FMO2-based microbial whole-cell catalysts for drug metabolite synthesis |
| Q41763477 | Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamide |
| Q41206250 | Identification of Flavin-Containing Monooxygenase 5 (FMO5) as a Regulator of Glucose Homeostasis and a Potential Sensor of Gut Bacteria |
| Q91802338 | Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation |
| Q40278415 | Identification of longevity-associated genes in long-lived Snell and Ames dwarf mice |
| Q47143254 | Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis |
| Q34510105 | Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis |
| Q37889234 | In vitro approaches to studying the metabolism of new psychoactive compounds |
| Q36662870 | Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics |
| Q33712363 | Isoform distinct time-, dose-, and castration-dependent alterations in flavin-containing monooxygenase expression in mouse liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment |
| Q27664240 | Joint Functions of Protein Residues and NADP(H) in Oxygen Activation by Flavin-containing Monooxygenase |
| Q28553912 | Juvenile Male Rats Exposed to a Low-Dose Mixture of Twenty-Seven Environmental Chemicals Display Adverse Health Effects |
| Q33976014 | Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide |
| Q39109460 | Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes |
| Q46305658 | Metabolic programming of the epigenome: host and gut microbial metabolite interactions with host chromatin |
| Q36753612 | Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouse |
| Q37060764 | Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes |
| Q53625601 | Microbial Flavoprotein Monooxygenases as Mimics of Mammalian Flavin-Containing Monooxygenases for the Enantioselective Preparation of Drug Metabolites. |
| Q36504395 | Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme |
| Q27728081 | Molecular Basis of C-N Bond Cleavage by the Glycyl Radical Enzyme Choline Trimethylamine-Lyase |
| Q42596962 | Molecular cloning, sequence characterization, SNP detection, and tissue expression analysis of duck FMO3 gene |
| Q47584047 | Molecular phylogeny, long-term evolution, and functional divergence of flavin-containing monooxygenases |
| Q36642348 | Nicotinamide N-oxidation by CYP2E1 in human liver microsomes |
| Q58086982 | Nicotine-N'-oxidation by flavin monooxygenase enzymes |
| Q38929936 | Non-cytochrome P450-mediated bioactivation and its toxicological relevance. |
| Q42708412 | Novel key metabolites reveal further branching of the roquefortine/meleagrin biosynthetic pathway. |
| Q36839694 | Osmotic regulation of a novel flavin-containing monooxygenase in primary cultured cells from rainbow trout (Oncorhynchus mykiss). |
| Q49397777 | Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer. |
| Q36870689 | Oxidative activation of thiacetazone by the Mycobacterium tuberculosis flavin monooxygenase EtaA and human FMO1 and FMO3. |
| Q36414574 | Oxidative stress-responsive transcription factor NRF2 is not indispensable for the human hepatic Flavin-containing monooxygenase-3 (FMO3) gene expression in HepG2 cells |
| Q38295313 | Pharmacogenetics of drug-metabolizing enzymes in Italian populations. |
| Q38127716 | Pharmacogenetics of olanzapine metabolism |
| Q34717044 | Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study |
| Q36245456 | Predicting the Metabolic Sites by Flavin-Containing Monooxygenase on Drug Molecules Using SVM Classification on Computed Quantum Mechanics and Circular Fingerprints Molecular Descriptors |
| Q90525391 | Production of drug metabolites by human FMO3 in Escherichia coli |
| Q46353725 | Protein kinase CK2 regulates redox homeostasis through NF-κB and Bcl-xL in cardiomyoblasts. |
| Q58838045 | Proteomic analysis of Bayvarol®resistance mechanisms in the honey bee parasiteVarroa destructor |
| Q35055301 | Quail FMO3 gene cloning, tissue expression profiling, polymorphism detection and association analysis with fishy taint in eggs |
| Q37062604 | Quantification of Flavin-containing Monooxygenases 1, 3, and 5 in Human Liver Microsomes by UPLC-MRM-Based Targeted Quantitative Proteomics and Its Application to the Study of Ontogeny. |
| Q48192886 | Range of therapeutic prothipendyl and prothipendyl sulfoxide concentrations in clinical blood samples |
| Q36252867 | Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety |
| Q98566142 | Regulation of dynamic pigment cell states at single-cell resolution |
| Q37731862 | Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population. |
| Q57730438 | Response to: “Prediction of Voriconazole Non-Linear Pharmacokinetics Using a Paediatric Physiologically Based Pharmacokinetic Modelling Approach” |
| Q27650474 | Revealing the moonlighting role of NADP in the structure of a flavin-containing monooxygenase |
| Q42180308 | Role of flavin-containing monooxygenase in oxidative metabolism of voriconazole by human liver microsomes |
| Q52652398 | Selective Heteroaryl N-Oxidation of Amine-Containing Molecules. |
| Q44169005 | Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes |
| Q38717340 | Specific features of pharmacokinetics in children. |
| Q51248022 | Structural mechanism for bacterial oxidation of oceanic trimethylamine into trimethylamine N-oxide. |
| Q90582114 | Structure-Guided Identification of a Small Molecule That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria |
| Q46361393 | Subclade of flavin-monooxygenases involved in aliphatic glucosinolate biosynthesis |
| Q28504955 | Synchronous evolution of an odor biosynthesis pathway and behavioral response |
| Q33562137 | Targeted sequencing identifies genetic polymorphisms of flavin-containing monooxygenase genes contributing to susceptibility of nicotine dependence in European American and African American |
| Q92511817 | Targeted ultra-deep sequencing of a South African Bantu-speaking cohort to comprehensively map and characterize common and novel variants in 65 pharmacologically-related genes |
| Q55082798 | Tetracycline-Inactivating Enzymes. |
| Q79734003 | The Arabidopsis flavin-dependent monooxygenase FMO1 is an essential component of biologically induced systemic acquired resistance |
| Q34176701 | The Flavin-Containing Monooxygenase 3 Gene and Essential Hypertension: The Joint Effect of Polymorphism E158K and Cigarette Smoking on Disease Susceptibility |
| Q38764871 | The Genetic Architecture of Coronary Artery Disease: Current Knowledge and Future Opportunities |
| Q92327987 | The Roles of Auxin Biosynthesis YUCCA Gene Family in Plants |
| Q54686050 | The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation. |
| Q34079767 | The in vitro metabolism of phospho-sulindac amide, a novel potential anticancer agent |
| Q35871695 | The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing |
| Q37772507 | The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism |
| Q37152243 | The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa |
| Q36473486 | The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines |
| Q34737067 | Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes. |
| Q38709842 | Transcriptome profiling of 3D co-cultured cardiomyocytes and endothelial cells under oxidative stress using a photocrosslinkable hydrogel system |
| Q34626393 | Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity |
| Q37357727 | Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease. |
| Q40752459 | Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease |
| Q27670798 | Two Structures of an N-Hydroxylating Flavoprotein Monooxygenase: ORNITHINE HYDROXYLASE FROM PSEUDOMONAS AERUGINOSA |
| Q38167838 | Use of density functional theory in drug metabolism studies. |
| Q59153034 | Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population |
| Q37645239 | Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism |
| Q37514335 | Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths. |
Search more.